|
Welcome to the Author Digest, February 2026 We hope you find it helpful. This digest goes out to all active Cochrane authors and will continue to be sent to authors who are opted in. Please review your communication preferences in your Cochrane Account and ensure you are opted in to communications.
|
|
|
|
|
|
Contents 1. The power of lived experience - Cochrane's Patient and Public Network 2. Reflections on involvement 3. Structuring analyses in RevMan 4. Recent updates to the Cochrane review RevMan templates 5. Seeking qualitative evidence synthesis author teams! 6. Methods Support Unit web clinics 7. Reminder: Subheading changes for diverse Cochrane review types in May 8. Reminder: Word limits coming in July 9. Covidence webinars on demand 10. Top tips for Cochrane authors
|
|
|
|
|
1. The power of lived experience - Cochrane's Patient and Public Network
|
|
|
|
|
2. Reflections on involvement
|
|
|
|
|
3. Structuring analyses in RevMan
|
|
|
|
|
4. Recent updates to the Cochrane review RevMan templates
|
|
|
Cochrane's review templates contains essential guidance on conducting your review and reporting your findings. Review templates are updated periodically to ensure authors have clear and current guidance on best practice for Cochrane reviews. We therefore advise that authors always open the template as a practice review in RevMan to ensure you are always viewing the latest version. The following review template sections have been updated for clarity in February 2026: - 'discussion > limitations of the review processes' - 'additional information > declarations of interest' - 'additional information > disclosure of AI use'For access to, and more details on using templates for reviews of intervention, prognosis, or qualitative studies, visit the RevMan Knowledge Base.
|
|
|
|
|
5. Seeking qualitative evidence synthesis author teams!
|
|
|
|
|
6. Methods Support Unit web clinic
|
|
|
The next MSU web clinic is open for sign-up. The March clinic focuses on INSPECT-SR - a tool for assessing the trustworthiness of randomised controlled trials. Don’t forget - if you sign-up, you will automatically be sent a recording of the session afterwards.
INSPECT-SR: A tool for assessing trustworthiness of randomised controlled trials: Thursday 19 March 2026: 9am UTC. Check time in your time zone.
|
|
|
|
|
7. Reminder: Subheading changes for diverse review types in May
|
|
|
Last year, Cochrane introduced new review subheadings for the following review types: diagnostic test accuracy, methodology, overview, prognosis, and qualitative evidence synthesis. Switching to the new subheadings is currently optional for these review types; however, from 4 May 2026, these review types will be updated in RevMan to include the new subheadings, unless they are already in editorial (e.g. submitted, under peer review, under revision). If you are planning your submission after 4 May, or if you think you might miss a submission deadline around this time, it may be helpful to switch to the new subheadings now. To switch to the new subheadings, you can use the new button, ‘update to latest heading structure,’ available on the right side of the RevMan Dashboard. For further details regarding these changes, please visit this page and the RevMan Knowledge Base.
|
|
|
|
|
8. Reminder: Word limits coming in July
|
|
|
|
|
9. Watch Covidence webinars on demand!
|
|
|
Missed a live session? You can watch recent Covidence webinars anytime with our on-demand recordings. These sessions offer practical guidance you can apply right away. Catch up on topics like: 🌐Covidence Step-by-step 🎯 A Practical Guide to Scoping Reviews: Purpose and Process 📝 Which Review Is Right for You? Understanding Review Types in Research Each webinar includes expert insights, step-by-step explanations, and examples to support review teams. Start watching here!
|
|
|
|
|
10. Top tips for Cochrane Authors
|
|
|
|
|
|
Adding Figures to Other supplementary materials: Following recent RevMan development, when you add a link to a figure in one of the Other supplementary materials, the figure is now inserted into the supplement and displayed at the bottom.
|
|
|
|
|
|
|